CHAMPIONS ONCOLOGY, INC.
CSBRUS売上高
$57M
百万USD
営業利益
$5M
百万USD
純利益
$5M
百万USD
ROE
124.6%
最新FY
EPS
$0.33
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $10M | $0M | $0.01 |
| FY2021 | Q2 | $10M | $0M | $0.00 |
| FY2021 | Q3 | $11M | $1M | $0.05 |
| FY2021 | FY | $41M | $0M | $0.02 |
| FY2022 | Q1 | $11M | $-0M | $-0.01 |
| FY2022 | Q2 | $12M | $0M | $0.02 |
| FY2022 | Q3 | $13M | $1M | $0.05 |
| FY2022 | FY | $49M | $1M | $0.04 |
| FY2023 | Q1 | $14M | $-0M | $-0.02 |
| FY2023 | Q2 | $14M | $-0M | $0.00 |
| FY2023 | Q3 | $13M | $-2M | $-0.18 |
| FY2023 | FY | $54M | $-5M | $-0.39 |
| FY2024 | Q1 | $13M | $-3M | $-0.19 |
| FY2024 | Q2 | $12M | $-2M | $-0.15 |
| FY2024 | Q3 | $12M | $-3M | $-0.19 |
| FY2024 | FY | $50M | $-7M | $-0.54 |
| FY2025 | Q1 | $14M | $1M | $0.09 |
| FY2025 | Q2 | $13M | $1M | $0.05 |
| FY2025 | Q3 | $17M | $4M | $0.31 |
| FY2025 | FY | $57M | $5M | $0.33 |
| FY2026 | Q1 | $14M | $-0M | $-0.03 |
| FY2026 | Q2 | $15M | $0M | $0.02 |
| FY2026 | Q3 | $17M | $-0M | $-0.02 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $27M | $32M | $41M | $49M | $54M | $50M | $57M |
| 営業利益 | $-10M | $-7M | $-1M | $0M | $-2M | $0M | $1M | $-5M | $-7M | $5M |
| 純利益 | $-10M | $-7M | $-1M | $0M | $-2M | $0M | $1M | $-5M | $-7M | $5M |
| 総資産 | $6M | $8M | $8M | $11M | $21M | $28M | $35M | $34M | $26M | $32M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $0M | $0M | $0M | $2M | $5M | $7M | $9M | $5M | $-2M | $4M |
| 営業CF | $-6M | $-3M | $-1M | $2M | $3M | $-2M | $6M | $4M | $-6M | $7M |
| EPS | $-1.20 | - | - | $0.01 | $-0.17 | $0.02 | $0.04 | $-0.39 | $-0.54 | $0.33 |
| BPS | $0.02 | $0.04 | $0.00 | $0.19 | $0.00 | $0.55 | $0.67 | $0.34 | $-0.14 | $0.27 |
| ROE | -4388.9% | -1721.0% | -49200.0% | 5.7% | -37.1% | 4.9% | 6.0% | -115.1% | 382.3% | 124.6% |